CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −5,358 | $436.00 | $2.3M | 13,305 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −1,922 | $437.56 | $841K | 11,383 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −2,086 | $438.34 | $914K | 9,297 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −5,302 | $439.27 | $2.3M | 3,995 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −1,238 | $440.54 | $545K | 2,757 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −1,205 | $441.88 | $532K | 1,552 |
| 2025-08-14 | Ausiello Dennis A Director | Sale 10b5-1 | −641 | $442.66 | $284K | 911 |
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −9,000 | 0 | ||
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,153 | 0 | ||
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,581 | 0 | ||
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,228 | 0 | ||
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,032 | 0 | ||
| 2025-08-14 | Ausiello Dennis A Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,454 | 0 | ||
| 2025-07-01 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Grant or award | +7,763 | 21,264 | ||
| 2025-06-02 | Greenstreet Yvonne Chief Executive Officer | Option exercise 10b5-1 | +12,080 | $119.13 | $1.4M | 61,028 |
| 2025-06-02 | Greenstreet Yvonne Chief Executive Officer | Option exercise 10b5-1 | +7,217 | $118.05 | $852K | 68,245 |
| 2025-06-02 | Greenstreet Yvonne Chief Executive Officer | Sale 10b5-1 | −19,297 | $306.00 | $5.9M | 48,948 |
| 2025-06-02 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,217 | 847 | ||
| 2025-06-02 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,080 | 839 | ||
| 2025-05-30 | Greenstreet Yvonne Chief Executive Officer | Option exercise 10b5-1 | +12,081 | $119.13 | $1.4M | 61,029 |
Page 27 of 41 · 816 trades